Extensive clinical experience with Taxotere® (T) is 1st and 2nd line treatment (tt) at 100 mg/m2 in locally advanced (LA) or metastatic breast cancer (MBC)

✍ Scribed by Wilke, H.; Joosens, E.; Hess, D.; Gozdz, S.; Cabral, S.; Orlandi, L.; Reksodiputro, H.; Khoo, K.S.; Boussard, B.; Köhne, H.

• Book ID: 122576394
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 152 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(99)81699-2